Modelling the effects of blood component storage lesions on the quality of haemostatic resuscitation in massive transfusion for trauma

Blood Transfusion

Volumn 15, Issue 2, 2017, Pages 153-157

  Mays, James A ^a   Hess, John R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Damage control resuscitation; Haemostatic resuscitation; Red cell loss of function; Red cell recovery

Indexed keywords

BLOOD CLOTTING FACTOR;

ARTICLE; BLOOD COMPONENT; BLOOD STORAGE; BLOOD TRANSFUSION; CRYOPRECIPITATE; ERYTHROCYTE; HEMODILUTION; HEMOSTASIS; HUMAN; INJURY; PLASMA; RESUSCITATION; THROMBOCYTE; THROMBOCYTE COUNT; BIOLOGICAL MODEL; BLOOD COMPONENT THERAPY; PROCEDURES; WOUNDS AND INJURIES;

BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; HUMANS; MODELS, BIOLOGICAL; RESUSCITATION; WOUNDS AND INJURIES;

EID: 85015079078     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2017.0310-16     Document Type: Article

References (12)

1. Apfelbaum JL, Nuttall GA, Connis RT. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015; 122: 241-75.
2. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17: 223-31.
3. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48: 1053-60.
4. Cancelas JA, Dumont LJ, Maes LA, et al. Additive solution-7 reduces the red blood cell cold storage lesion. Transfusion 2015; 55: 491-8.
5. Kornblith LZ, Howard BM, Cheung CK, et al. The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants. J Trauma Acute Care Surg 2014; 77: 818-27.
6. Cardigan R, Van der Meer PF, Pergande C, et al. Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study. Transfusion 2011; 51: 50S-7S.
7. Downes KA, Wilson E, Yomtovian R, Sarode R. Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 2001; 41: 570.
8. Sharma AD, Sreeram G, Erb T, Grocott HP. Solvent-detergenttreated fresh frozen plasma: A superior alternative to standard fresh frozen plasma? J Cardiothor Vasc An 2000; 14: 712-7.
9. Triulzi DJ, Assmann SF, Strauss RG, et al. The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. Blood 2012; 119: 5553-62.
10. Hess JR, Trachtenberg FL, Assmann SF, et al. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial. Vox Sanguinis 2016; 111: 281-91.
11. Butler C, Doree C, Estcourt LJ, et al. Pathogen-reduced platelets for the prevention of bleeding. The Cochrane Database Syst Rev 2013; 3: CD009072.
12. AuBuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 1335-41.